HISTORY

BHCRG is a 2nd generation company, working on a 2nd generation family of drugs.

COMPANY HISTORY: A 2ND GENERATION COMPANY

Early 1900s: Dale’s grandfather (AC), won a hotel as payment for poker debts. The hotel was located on Vermont Avenue in Washington, D.C. AC and friends mistakenly renamed it “The Burlington Hotel,” after the capital of Vermont (Montpelier).
– • –
Late 1900s: AC’s children transferred ownership of the hotel to The Burlington HC, Inc.
– • –
2004: hotel property sold.
– • –
2012: Dale and Vernon established a new company (The Burlington HC Research Group, Inc.) based upon new drug discoveries financed by the original company.

DRUG FAMILY HISTORY: A 2ND GENERATION FAMILY OF DRUGS

Early 1950s: US military developed and investigated new drugs (called phosphorothioates) as protectants against radiation.
– • –
1950s to present: range of activities of this drug family and/or its active metabolites expanded to include:
– Anti-cancer effect
– Anti-viral effects
– Other beneficial effects
– • –
Problems with drug delivery, metabolism, and toxicity issues for phosphorothioates prevented wide spread use.
– • –
2010 to present: the Walkers discovered new solutions to these problems; this resulted in development of the BRG family of drugs.
– • –
2015 to present: the first BRG drug was synthesized; testing is ongoing.